The illustration shows ponsegromab, represented as a y-shaped antibody, on the outside of the body. An arrow points from ponsegromab to the stomach, showing the antibody binding with GDF-15, and an arrow to the brain, where GDF-15 is blocked from interacting with GFRAL.